CD-38 Market Segmentation by Indications: Trends and Growth Factors
he CD-38 market is set to expand across multiple indications, fueled by strong R&D investments, promising clinical trial results, and the increasing prevalence of blood cancers. With numerous new therapies in the CD-38 pipeline, the market is likely to witness a broadening of treatment